반려동물용 백신 시장 보고서(2025년)

Companion animal vaccines are substances designed to stimulate the production of antibodies and confer immunity against one or more diseases in pets, including dogs, birds, and cats. They serve not only to protect against diseases but also to enhance food digestion, boost immunity, promote weight gain, and generate high-quality meat for commercial purposes.

The primary types of companion animal veterinary vaccines are inactivated, live attenuated, recombinant, and other products. Recombinant vaccines are created using recombinant DNA technology, involving the insertion of DNA encoding an antigen (e.g., a bacterial surface protein) into bacterial or mammalian cells, expression of the antigen within these cells, and subsequent purification. These products can be administered through oral, parenteral, and other routes of administration and are distributed through various channels, including veterinary hospitals, veterinary clinics, pharmacies, drug stores, and other distribution channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The companion animal veterinary vaccines research report is one of a series of new reports from The Business Research Company that provides companion animal veterinary vaccines statistics, including companion animal veterinary vaccines industry global market size, regional shares, competitors with companion animal veterinary vaccines share, detailed companion animal veterinary vaccines segments, market trends and opportunities, and any further data you may need to thrive in the companion animal veterinary vaccines industry. This companion animal veterinary vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The companion animal veterinary vaccines market size has grown strongly in recent years. It will grow from $3.7 billion in 2024 to $3.94 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to pet ownership growth, preventive healthcare, zoonotic diseases, advancements in vaccine technology.

The companion animal veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $5.05 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing pet population, preventive healthcare awareness, technology and vaccine development, customized vaccination plans. Major trends in the forecast period include comprehensive vaccination programs, advanced vaccine technologies, vector-borne disease control, vaccination clinics and mobile services.

The forecast of 6.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on viral seed stock and sterile growth media flown in from France are set to lengthen production cycles and inflate batch costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the companion animal veterinary vaccine market during the forecast period is driven by the increasing pet ownership among Gen X and Gen Y adults. According to the APPA, millennials (Gen Y) constitute the largest group of pet owners across different types of pets. Over 80% of Gen Y and Gen Z individuals own dogs, while fewer than 50% own cats. Additionally, the trend of multiple pet ownership is becoming increasingly common worldwide. For example, in 2022, as reported by Animal Medicines Australia, an Australia-based non-governmental organization, pet ownership in Australia saw significant growth. The number of pet owners reached 28,730.8 in 2022, compared to 39% in 2021, reflecting a 24% increase and a strong upward trend in pet adoption and care investment. This rise in pet ownership highlights the growing popularity of pets in Australian households and contributes to the expansion of the companion animal veterinary vaccine market.

The growth of the companion animal veterinary vaccines market is further driven by the increasing expenditure on pet health. Pet health is vital for the overall well-being of animals, including dogs, cats, birds, small mammals, and other domesticated pets. Regular vaccinations are a cornerstone of preventive pet healthcare, benefiting not only individual pet health but also the broader pet community. In June 2023, the American Pet Products Association reported that Americans spent $136.8 billion on pet health in 2022, representing a 10.68% increase from 2021, when spending amounted to $123.6 billion. Additionally, sales of pet food and treats accounted for $58.1 billion. This upward trajectory in pet health spending is propelling the growth of the companion animal veterinary vaccines market.

Companies operating in the companion animal veterinary vaccine industry are increasingly engaging in collaborations and partnerships to drive product innovations. To thrive in the competitive veterinary market, these companies are expanding into new geographic regions and developing innovative products by leveraging their skills and expertise through partnerships with other players. For example, Merck & Co.'s subsidiary, MSD Animal Health, has established a strategic partnership with Vinovo B.V., a division of Viscon Hatchery Automation, a leading hatchery automation company. This partnership aims to set a new standard in safe and effective Vinovo vaccination, enhancing bird welfare and reducing vaccine reactions.

Leading companies in the companion animal vaccine market are introducing innovative vaccines to enhance their market presence and revenue. For instance, in September 2022, Merck Animal Health (MSD Animal Health), a US-based animal pharmaceutical manufacturer, launched Nobivac Intra-Trac Oral BbPi, an oral vaccine designed to protect dogs against Bordetella bronchiseptica and canine parainfluenza virus. This groundbreaking vaccine, the first of its kind, provides mucosal immunity via the proprietary Immuno-Mist-R(TM) delivery system, ensuring comprehensive spray coverage. This innovation simplifies administration for veterinarians while improving comfort for dogs. Designed for dogs aged seven weeks and older, it is both thimerosal-free and preservative-free, prioritizing safety while streamlining the protection of canine respiratory health.

In June 2023, Mars Inc., a US-based manufacturing company, acquired Heska Corp. for $1.3 billion. This acquisition bolsters Mars Petcare's veterinary care offerings and underscores its commitment to advancing pet health. Heska is now integrated into Mars Petcare's science and diagnostics division, which includes Antech Diagnostics. This integration enhances diagnostic capabilities for veterinary professionals and pet owners by expanding access to advanced diagnostic technologies and accelerating research and development in veterinary healthcare. Heska Corp., a US-based veterinary services company, specializes in developing, manufacturing, and commercializing advanced veterinary diagnostics and vaccines for canine and feline health.

Major companies operating in the companion animal veterinary vaccines market include C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, Heska Corp., Merck and Co. Inc., Elanco Animal Health Incorporated, Zoetis Inc., Ceva Sante Animale SA, Bayer AG, Neogen Corporation, ImmuCell Corporation, Intervet Inc., Vetoquinol SA, IDEXX Laboratories Inc., Merial Inc., Biogenesis Bago SA, Hipra India Pvt. Ltd., Bimeda Animal Health Limited, Phibro Animal Health Corporation, Nexvet Biopharma plc, Bioniche Animal Health Canada Inc., Bioiberica S.A., Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Dechra Pharmaceuticals PLC, Kyoritsu Seiyaku Corporation, VDS Pharma Animal Health, Kepro Technologies Private Limited, ECO Animal Health Group plc, Biostadt India Limited, bio-pharmaceutical company, Choong Ang Vaccine Laboratories Co. Ltd., CZ Veterinaria S.A.

North America was the largest region in the companion animal veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the companion animal veterinary vaccines market. The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the companion animal veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The companion animal veterinary vaccine market consists of sales of toxoid vaccines, viral vector vaccines, messenger RNA vaccines, and conjugated vaccines. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Companion Animal Veterinary Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on companion animal veterinary vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for companion animal veterinary vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The companion animal veterinary vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Inactivated; Live Attenuated; Recombinant; Other Products
• 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores; Other Distribution Channels
• Subsegments:
• 1) By Inactivated: Inactivated Canine Vaccines; Inactivated Feline Vaccines; Inactivated Vaccine Combinations; Other Inactivated Vaccines
• 2) By Live Attenuated: Live Attenuated Canine Vaccines; Live Attenuated Feline Vaccines; Live Attenuated Vaccine Combinations; Other Live Attenuated Vaccines
• 3) By Recombinant: Recombinant Canine Vaccines; Recombinant Feline Vaccines; Recombinant Vaccine Combinations; Other Recombinant Vaccines
• 4) By Other Products: DNA Vaccines; Subunit Vaccines; Toxoid Vaccines; Other Veterinary Vaccine Products
• Companies Mentioned: C.H. Boehringer Sohn AG & Co. KG; Eli Lilly and Company; Heska Corp.; Merck and Co. Inc.; Elanco Animal Health Incorporated; Zoetis Inc.; Ceva Sante Animale SA; Bayer AG; Neogen Corporation; ImmuCell Corporation; Intervet Inc.; Vetoquinol SA; IDEXX Laboratories Inc.; Merial Inc.; Biogenesis Bago SA; Hipra India Pvt. Ltd.; Bimeda Animal Health Limited; Phibro Animal Health Corporation; Nexvet Biopharma plc; Bioniche Animal Health Canada Inc.; Bioiberica S.A.; Laboratorios Hipra S.A.; Norbrook Laboratories Ltd.; Dechra Pharmaceuticals PLC; Kyoritsu Seiyaku Corporation; VDS Pharma Animal Health; Kepro Technologies Private Limited; ECO Animal Health Group plc; Biostadt India Limited; bio-pharmaceutical company; Choong Ang Vaccine Laboratories Co. Ltd.; CZ Veterinaria S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Companion Animal Veterinary Vaccines Market Characteristics

3. Companion Animal Veterinary Vaccines Market Trends And Strategies

4. Companion Animal Veterinary Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Companion Animal Veterinary Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Companion Animal Veterinary Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Companion Animal Veterinary Vaccines Market Growth Rate Analysis
• 5.4. Global Companion Animal Veterinary Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Companion Animal Veterinary Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Companion Animal Veterinary Vaccines Total Addressable Market (TAM)

6. Companion Animal Veterinary Vaccines Market Segmentation

• 6.1. Global Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated
• Live Attenuated
• Recombinant
• Other Products
• 6.2. Global Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes of Administration
• 6.3. Global Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies and Drug Stores
• Other Distribution Channels
• 6.4. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Canine Vaccines
• Inactivated Feline Vaccines
• Inactivated Vaccine Combinations
• Other Inactivated Vaccines
• 6.5. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Canine Vaccines
• Live Attenuated Feline Vaccines
• Live Attenuated Vaccine Combinations
• Other Live Attenuated Vaccines
• 6.6. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Recombinant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Canine Vaccines
• Recombinant Feline Vaccines
• Recombinant Vaccine Combinations
• Other Recombinant Vaccines
• 6.7. Global Companion Animal Veterinary Vaccines Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Other Veterinary Vaccine Products

7. Companion Animal Veterinary Vaccines Market Regional And Country Analysis

• 7.1. Global Companion Animal Veterinary Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Companion Animal Veterinary Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Companion Animal Veterinary Vaccines Market

• 8.1. Asia-Pacific Companion Animal Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Companion Animal Veterinary Vaccines Market

• 9.1. China Companion Animal Veterinary Vaccines Market Overview
• 9.2. China Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Companion Animal Veterinary Vaccines Market

• 10.1. India Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Companion Animal Veterinary Vaccines Market

• 11.1. Japan Companion Animal Veterinary Vaccines Market Overview
• 11.2. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Companion Animal Veterinary Vaccines Market

• 12.1. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Companion Animal Veterinary Vaccines Market

• 13.1. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Companion Animal Veterinary Vaccines Market

• 14.1. South Korea Companion Animal Veterinary Vaccines Market Overview
• 14.2. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Companion Animal Veterinary Vaccines Market

• 15.1. Western Europe Companion Animal Veterinary Vaccines Market Overview
• 15.2. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Companion Animal Veterinary Vaccines Market

• 16.1. UK Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Companion Animal Veterinary Vaccines Market

• 17.1. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Companion Animal Veterinary Vaccines Market

• 18.1. France Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Companion Animal Veterinary Vaccines Market

• 19.1. Italy Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Companion Animal Veterinary Vaccines Market

• 20.1. Spain Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Companion Animal Veterinary Vaccines Market

• 21.1. Eastern Europe Companion Animal Veterinary Vaccines Market Overview
• 21.2. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Companion Animal Veterinary Vaccines Market

• 22.1. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Companion Animal Veterinary Vaccines Market

• 23.1. North America Companion Animal Veterinary Vaccines Market Overview
• 23.2. North America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Companion Animal Veterinary Vaccines Market

• 24.1. USA Companion Animal Veterinary Vaccines Market Overview
• 24.2. USA Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Companion Animal Veterinary Vaccines Market

• 25.1. Canada Companion Animal Veterinary Vaccines Market Overview
• 25.2. Canada Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Companion Animal Veterinary Vaccines Market

• 26.1. South America Companion Animal Veterinary Vaccines Market Overview
• 26.2. South America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Companion Animal Veterinary Vaccines Market

• 27.1. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Companion Animal Veterinary Vaccines Market

• 28.1. Middle East Companion Animal Veterinary Vaccines Market Overview
• 28.2. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Companion Animal Veterinary Vaccines Market

• 29.1. Africa Companion Animal Veterinary Vaccines Market Overview
• 29.2. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Companion Animal Veterinary Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Companion Animal Veterinary Vaccines Market Competitive Landscape
• 30.2. Companion Animal Veterinary Vaccines Market Company Profiles
  • 30.2.1. C.H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Heska Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Companion Animal Veterinary Vaccines Market Other Major And Innovative Companies

• 31.1. Zoetis Inc.
• 31.2. Ceva Sante Animale SA
• 31.3. Bayer AG
• 31.4. Neogen Corporation
• 31.5. ImmuCell Corporation
• 31.6. Intervet Inc.
• 31.7. Vetoquinol SA
• 31.8. IDEXX Laboratories Inc.
• 31.9. Merial Inc.
• 31.10. Biogenesis Bago SA
• 31.11. Hipra India Pvt. Ltd.
• 31.12. Bimeda Animal Health Limited
• 31.13. Phibro Animal Health Corporation
• 31.14. Nexvet Biopharma plc
• 31.15. Bioniche Animal Health Canada Inc.

32. Global Companion Animal Veterinary Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Companion Animal Veterinary Vaccines Market

34. Recent Developments In The Companion Animal Veterinary Vaccines Market

35. Companion Animal Veterinary Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Companion Animal Veterinary Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Companion Animal Veterinary Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Companion Animal Veterinary Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer